HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH Patent applications |
Patent application number | Title | Published |
20150079154 | MEDICAMENT FOR TREATMENT OF LIVER CANCER - The invention provides a pharmaceutical composition comprising Sorafenib in combination with an inhibitor of a specific kinase inhibitor as a medicament for the treatment or prevention of liver cancer. | 03-19-2015 |
20140256618 | Haprolid and Derivatives Thereof as Inhibitors of HCV - The present invention describes new compounds (e.g. Haprolid) of formula (I) and their use as antiviral agents such as inhibitors of hepatitis C virus (HCV): | 09-11-2014 |
20140141510 | MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE - The present invention relates to the use of a compound which inhibits the activity of MKK4 as a medicament for the treatment of a patient suffering from an impaired liver function, to the use of a compound as a medicament for the treatment of liver failure, including acute/fulminant or chronic liver failure and/or for increasing the regeneration of liver tissue in a patient. | 05-22-2014 |
20140051036 | TOOTH FILLING MATERIALS AND DENTAL VARNISH FOR INHIBITING THE FORMATION OF A BIOFILM OF STREPTOCOCCUS MUTANS AND THE PRODUCTION THEREOF - There are described tooth filling materials and dental varnishes for inhibiting the biofilm formation of | 02-20-2014 |
20120251579 | COMPOSITIONS FOR GENERATING AN ANTIGEN SPECIFIC IMMUNE RESPONSE - The present invention provides for the purposeful utilisation of the induction of senescence in eukaryotic cells for induction of an antigen specific immune response. Such cells can be normal cells, pre-malignant and malignant cells as well as virally or bacterially infected cells, for the generation of an immune response, preferably a cellular or humoral immune response comprising T-cells and/or B-cells, whose immune response is directed specifically against antigens from those cells in which senescence was induced and then comprises an immune response against the senescent cells itself as well as to the non-senescent counterparts harbouring the same antigens. | 10-04-2012 |
20120184482 | Novel Ubiquitin-Isopeptide Probes - The invention relates to a ubiquitin-isopeptide probe (hereinafter also referred to as UIPP), a method for its preparation, and its use. The invention also provides a method for isolating a deubiquitinating enzyme and a method for activity-based protein profiling (ABPP). | 07-19-2012 |
20090258870 | NOVEL ANSAMITOCIN DERIVATIVES - Provided are among other things ansamitocin derivatives, pharmaceutical compositions comprising these novel ansamitocin derivatives, methods for the production of the ansamitocin derivatives and their use for the treatment of cancer. | 10-15-2009 |